Lv11
86 积分 2026-02-03 加入
YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer
6小时前
待确认
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate Cancer
2个月前
已关闭
Abstract PS1-10-08: Er riptacs drive tumor selective cell death in post-cdk4/6i resistance settings and demonstrate oral efficacy in cdx and pdx models
3个月前
已关闭
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate
4个月前
已完结
Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives
4个月前
已完结
Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis
6个月前
已完结
Peptide design through binding interface mimicry with PepMimic
6个月前
已完结
皖公网安备34019202002308
